1. Home
  2. GDTC vs CTRM Comparison

GDTC vs CTRM Comparison

Compare GDTC & CTRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • CTRM
  • Stock Information
  • Founded
  • GDTC 2018
  • CTRM 2016
  • Country
  • GDTC Singapore
  • CTRM Cyprus
  • Employees
  • GDTC N/A
  • CTRM N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • CTRM Marine Transportation
  • Sector
  • GDTC Health Care
  • CTRM Consumer Discretionary
  • Exchange
  • GDTC Nasdaq
  • CTRM Nasdaq
  • Market Cap
  • GDTC 28.0M
  • CTRM 20.5M
  • IPO Year
  • GDTC 2023
  • CTRM N/A
  • Fundamental
  • Price
  • GDTC $2.30
  • CTRM $2.17
  • Analyst Decision
  • GDTC Buy
  • CTRM
  • Analyst Count
  • GDTC 1
  • CTRM 0
  • Target Price
  • GDTC $5.00
  • CTRM N/A
  • AVG Volume (30 Days)
  • GDTC 29.9K
  • CTRM 33.1K
  • Earning Date
  • GDTC 01-01-0001
  • CTRM 05-16-2025
  • Dividend Yield
  • GDTC N/A
  • CTRM N/A
  • EPS Growth
  • GDTC N/A
  • CTRM N/A
  • EPS
  • GDTC N/A
  • CTRM 2.39
  • Revenue
  • GDTC $368,838.00
  • CTRM $76,443,340.00
  • Revenue This Year
  • GDTC N/A
  • CTRM N/A
  • Revenue Next Year
  • GDTC N/A
  • CTRM N/A
  • P/E Ratio
  • GDTC N/A
  • CTRM $0.89
  • Revenue Growth
  • GDTC 264.63
  • CTRM N/A
  • 52 Week Low
  • GDTC $1.20
  • CTRM $1.98
  • 52 Week High
  • GDTC $4.05
  • CTRM $5.49
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 46.24
  • CTRM 47.06
  • Support Level
  • GDTC $2.21
  • CTRM $2.07
  • Resistance Level
  • GDTC $2.56
  • CTRM $2.24
  • Average True Range (ATR)
  • GDTC 0.13
  • CTRM 0.11
  • MACD
  • GDTC -0.00
  • CTRM 0.01
  • Stochastic Oscillator
  • GDTC 31.58
  • CTRM 47.50

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About CTRM Castor Maritime Inc.

Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.

Share on Social Networks: